PROSHARES TR - HGH YLD INT RATE (HYHG) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / HGH YLD INT RATE
Symbol
HYHG
Price per share
$64.40
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,064,988
Total reported value
$69,309,658
% of total 13F portfolios
0%
Share change
+48,579
Value change
+$3,163,434
Number of holders
43
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 43 institutional investors reported holding 1,064,988 shares of PROSHARES TR - HGH YLD INT RATE (HYHG).

Institutional Holders of PROSHARES TR - HGH YLD INT RATE (HYHG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 17,915 $1,153,726 +$95,956 $64.40 1
2025 Q3 1,064,988 $69,309,658 +$3,163,434 $65.14 43
2025 Q2 1,021,278 $66,179,399 -$16,376,435 $64.80 40
2025 Q1 1,256,343 $80,472,569 +$13,935,983 $64.05 41
2024 Q4 1,047,143 $68,658,349 +$13,454,562 $65.54 46
2024 Q3 840,309 $54,458,412 -$728,517 $64.80 36
2024 Q2 852,234 $54,655,553 -$7,530,121 $64.14 41
2024 Q1 973,878 $62,224,799 +$9,036,407 $63.92 40
2023 Q4 648,487 $40,785,677 +$1,949,212 $62.90 37
2023 Q3 783,451 $48,182,645 -$678,674 $61.52 38
2023 Q2 794,558 $48,603,827 -$6,888,034 $61.18 34
2023 Q1 899,176 $53,690,096 +$751,348 $59.72 34
2022 Q4 881,488 $51,502,053 -$1,077,358 $58.40 37
2022 Q3 901,319 $52,061,762 -$1,004,582 $57.74 37
2022 Q2 937,939 $77,275 -$1,160,547 $0.06 36
2022 Q1 1,030,124 $64,295,712 +$2,174,544 $62.42 31
2021 Q4 907,130 $56,922,954 +$2,882,260 $62.75 32
2021 Q3 857,271 $54,040,135 +$11,774,999 $63.04 27
2021 Q2 658,346 $41,584,009 +$11,574,912 $63.16 24
2021 Q1 483,340 $30,564,847 +$5,097,327 $63.24 25
2020 Q4 402,494 $24,994,454 -$5,124,409 $62.10 23
2020 Q3 486,197 $29,031,058 +$7,734,219 $59.70 27
2020 Q2 356,704 $20,734,066 -$23,622,494 $58.13 27
2020 Q1 762,728 $42,000,331 +$13,544,102 $55.07 25
2019 Q4 514,917 $33,693,649 -$581,197 $65.43 30
2019 Q3 524,305 $33,840,696 +$5,274,611 $64.54 31
2019 Q2 442,212 $29,047,129 -$8,989,147 $65.68 31
2019 Q1 605,823 $39,959,449 -$26,422,668 $65.96 37
2018 Q4 1,023,920 $63,573,981 -$20,670,713 $62.09 34
2018 Q3 1,277,836 $87,511,081 -$5,988,239 $68.48 31
2018 Q2 1,320,322 $88,213,200 -$7,299,137 $66.81 29
2018 Q1 1,470,057 $98,293,453 +$41,537,119 $66.86 30
2017 Q4 808,369 $54,367,384 -$2,727,704 $67.25 28
2017 Q3 839,094 $57,343,734 +$4,199,854 $68.33 28
2017 Q2 789,406 $54,147,744 +$607,349 $68.60 29
2017 Q1 774,785 $53,216,000 +$14,096,810 $68.69 28
2016 Q4 569,509 $38,997,000 +$4,204,370 $68.48 22
2016 Q3 508,517 $33,882,000 +$1,197,556 $66.64 24
2016 Q2 490,577 $31,296,000 -$1,070,492 $63.81 23
2016 Q1 506,920 $31,729,000 -$7,172,590 $62.63 23
2015 Q4 618,450 $38,694,000 -$9,521,975 $62.57 22
2015 Q3 755,599 $49,197,000 -$2,034,007 $65.07 25
2015 Q2 786,081 $56,867,858 +$7,752,648 $72.35 28
2015 Q1 640,857 $46,998,003 -$7,486,815 $73.34 24
2014 Q4 468,330 $34,301,296 +$27,207,293 $73.25 32
2014 Q3 43,987 $3,378,000 +$1,998,153 $76.80 3
2014 Q2 17,945 $1,444,000 +$11,750 $80.36 3
2014 Q1 17,799 $1,434,000 -$94,693 $80.36 3